Condition

Brain Tumor

ClinicalTrials.gov condition label

Clinical trials27

Recruiting11

Common interventions25

Lead sponsors shown15

Clinical trials

27 shown

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossNCT06810544 · 2025-03-24

Brodalumab in the Treatment of Immune-Related Adverse EventsNCT06673329 · 2025-03-11

Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal AssessmentNCT06352710 · 2023-06-12

Remote Neuropsychological Assessment of Patients With Neurological Disorders and InjuriesNCT05819008 · 2023-03-10

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor PatientsNCT05549024 · 2022-08-16

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain MetsNCT05317858 · 2022-08-12

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain MetastasesNCT04899908 · 2021-09-15

18F-DOPA II - PET Imaging OptimizationNCT04706910 · 2021-01-20

Engineered TILs/CAR-TILs to Treat Advanced Solid TumorsNCT04842812 · 2021-01-01

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNCT04075305 · 2019-02-01

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsNCT03175224 · 2017-09-27

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentNCT06322342 · 2024-08-15

CALM: Managing Distress in Malignant Brain CancerNCT06180460 · 2023-11-10

The Effect of 360° Virtual Reality Movies on Fear and AnxietyNCT06199050 · 2023-06-16

The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of ActionNCT05926336 · 2023-05-23

Post Market Clinical Follow-up of CODMAN CERTAS Programmable ValveNCT05397106 · 2023-01-24

ACTIVE_NOT_RECRUITING

Dynamic Decompressive CraniotomyNCT05051488 · 2022-04-30

Neuropsychology of Financial CapacityNCT05791006 · 2021-08-04

Improving Social Cognition and Social Behaviour in Various Brain DisordersNCT06330298 · 2021-05-31

The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05

Closed vs. Open Face Masks for Cranial RadiotherapyNCT04079595 · 2019-12-09

Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?NCT06251830 · 2018-09-01

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133NCT02541370 · 2015-06-01

PatientSpot Formerly Known as ArthritisPowerNCT03840928 · 2015-04-01

Ultrasound Guided Central Vein Catheterization and ComplicationsNCT01510743 · 2012-01-30

A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical PatientsNCT00952081 · 2009-07-01

Factor XIII and Pulmonary Embolism in Neurosurgical PatientsNCT01106937 · 2007-10-01

Common interventions

Leading sponsors

Apollomics Inc.1 Brian Henick, MD1 Brigham and Women's Hospital1 Cantonal Hospital of St. Gallen1 Chinese PLA General Hospital1 Global Healthy Living Foundation1 InSightec1 Integra LifeSciences Corporation1 IRCCS Fondazione Stella Maris1 Istituto Auxologico Italiano1 Kaohsiung Medical University Chung-Ho Memorial Hospital1 Ludwig-Maximilians - University of Munich1 Maastricht Radiation Oncology1 NYU Langone Health1 Peking Union Medical College Hospital1

Trial status mix

RECRUITING11

COMPLETED9

UNKNOWN6

ACTIVE_NOT_RECRUITING1

Phase mix

NA5

PHASE25

PHASE14

PHASE32

PHASE42

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.